Abstract:Aims/hypothesis: Pregnancy is accompanied by maternal metabolic adaptations to ensure fetal growth and development, including insulin resistance, which occurs primarily during the second and third trimesters of pregnancy, and a decrease in fasting blood sugar levels over the course of pregnancy. Glucose-related traits are regulated by genetic and environmental factors and modulated by physiological variations throughout the life course. We addressed the hypothesis that there are both overlaps and differences between genetic variants associated with glycaemia-related traits during and outside of pregnancy. Methods: Genome-wide SNP data were used to identify genetic variations associated with glycaemia-related traits measured during an OGTT performed at ~28 weeks' gestation in 8067 participants in the Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study. Associations outside of pregnancy were determined in 3977 individuals who also participated in the HAPO Follow-Up Study at 11-14 years postpartum. A Bayesian classification algorithm was used to determine whether SNPs associated with fasting and 2 h glucose and fasting C-peptide during pregnancy had a pregnancy-predominant effect vs a similar effect during pregnancy and postpartum. Results: SNPs in six loci (GCKR, G6PC2, GCK, PPP1R3B, PCSK1 and MTNR1B) were significantly associated with fasting glucose during pregnancy, while SNPs in CDKAL1 and MTNR1B were associated with 1 h glucose and SNPs in MTNR1B and HKDC1 were associated with 2 h glucose. Variants in CDKAL1 and MTNR1B were associated with insulin secretion during pregnancy. Variants in multiple loci were associated with fasting C-peptide during pregnancy, including GCKR, IQSEC1, PPP1R3B, IGF1 and BACE2. GCKR and BACE2 were associated with 1 h C-peptide and GCKR, IQSEC1 and BACE2 with insulin sensitivity during pregnancy. The associations of MTNR1B with 2 h glucose, BACE2 with fasting and 1 h C-peptide and insulin sensitivity, and IQSEC1 with fasting C-peptide and insulin sensitivity that we identified during pregnancy have not been previously reported in non-pregnancy cohorts. The Bayesian classification algorithm demonstrated that the magnitude of effect of the lead SNP was greater during pregnancy compared with 11-14 years postpartum in PCSK1 and PPP1R3B with fasting glucose, in three loci, including MTNR1B, with 2 h glucose, and in six loci, including IGF1, with fasting C-peptide. Conclusions/interpretation: Our findings support the hypothesis that there are both overlaps and differences between the genetic architecture of glycaemia-related traits during and outside of pregnancy. Genetic variants at several loci, including PCSK1, PPP1R3B, MTNR1B and IGF1, appear to influence glycaemic regulation in a unique fashion during pregnancy. Future studies in larger cohorts will be needed to replicate the present findings, fully characterise the genetics of maternal glycaemia during pregnancy and determine similarities to and differences from the non-gravid state.

The Impact of Genetic Variants for Different Physiological Characterization of Type 2 Diabetes Loci on Gestational Insulin Signaling in Nondiabetic Pregnant Chinese Women

The Association of Gene Variants in the Vitamin D Metabolic Pathway and Its Interaction with Vitamin D on Gestational Diabetes Mellitus: A Prospective Cohort Study

Association of Variants in CDKN2A/2B and CDKAL1 Genes with Gestational Insulin Sensitivity and Disposition in Pregnant Han Chinese Women

Heterogeneous Impact of Type 2 Diabetes Mellitus-Related Genetic Variants on Gestational Glycemic Traits: Review and Future Research Needs

Identification and Potential Clinical Utility of Common Genetic Variants in Gestational Diabetes among Chinese Pregnant Women

Genetic Variants and Clinical Relevance Associated with Gestational Diabetes Mellitus in Chinese Women: a Case-Control Study.

Genome-wide Analysis Study of Gestational Diabetes Mellitus and Related Pathogenic Factors in a Chinese Han Population

Common Genetic Variants in ADCY5 and Gestational Glycemic Traits

Novel insights into the genetic architecture of pregnancy glycemic traits from 14,744 Chinese maternities

Genetic variants of the GLP-1R gene affect the susceptibility and glucose metabolism of gestational diabetes mellitus: a two-center nested case‒control study

Association of Genetic Variants of Melatonin Receptor 1B with Gestational Plasma Glucose Level and Risk of Glucose Intolerance in Pregnant Chinese Women.

Micro-ribonucleic Acid-Binding Site Variants of Type 2 Diabetes Candidate Loci Predispose to Gestational Diabetes Mellitus in Chinese Han Women.

Genetic Variants in Vitamin D Signaling Pathways and Risk of Gestational Diabetes Mellitus

Genetics of glucose homeostasis in pregnancy and postpartum

Association between genetic variations in MTNR1A and MTNR1B genes and gestational diabetes mellitus in Han Chinese women.

No Association Detected Between Seven Common Variants in the CDKAL1 Gene and Gestational Glycemic Traits.

Functional genetic variants and susceptibility and prediction of gestational diabetes mellitus

Association of Insulin Receptor Substrate-2 Gene 1057G/D Polymorphism with Gestational Diabetes Mellitus

Genetic Susceptibility to Gestational Diabetes Mellitus in a Chinese Population

Effects of Gck, Gckr, G6pc2 and Mtnr1b Variants on Glucose Metabolism and Insulin Secretion

49-OR: Genetic Variants Influencing Insulin Deficiency and Resistance Are Associated with Adverse Pregnancy Outcomes